Company Analysis

Castle Biosciences, Inc. (CSTL)

Nasdaq: CSTL · Services-Medical Laboratories · Friendswood, TX · filing with the SEC since 2008
Grade6.1
◀ Past 5.6● Present 7.3▶ Future 5.1

Who runs Castle Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
17 people on the record since 2019
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Juvenal Tobin WChief Commercial OfficerApr 2021Nov 12, 202623 · $3.4M
Maetzold Derek JPres. & Chief Exec. OfficerJul 2019Nov 4, 2026177 · $11.8M
Oelschlager Kristen MChief Operating OfficerApr 2021Oct 5, 202614 · $2.4M
Stokes FrankChief Financial OfficerJul 2019Aug 18, 20265 · $1.3M
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bradbury DanieldirectorJul 2019Jun 1, 2026none
Caple KimdirectorJul 2021Jun 1, 2026none
Cole G BradleydirectorJul 2019Jun 1, 20262 · $200,000
Cotton RodneydirectorMar 2024Jun 1, 2026none
Goldberg EllendirectorJul 2021Jun 1, 2026none
Harrison MilesdirectorApr 2020Jun 1, 2026none
Olson TiffanydirectorMay 2021Jun 1, 2026none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CSTL · research, not advice